Stereotactic body radiation therapy as an emerging ablative therapy for recurrent gynecologic cancer: Early disease and quality of life outcomes from a phase II trial

Mantz, C.A.; Shahin, Fadi Abu; Grendys, Edward C.; Orr, James W.

doi:10.1016/j.ygyno.2011.12.305

Search citation statements

Order By: Relevance

Paper Sections

Select...

Gynecological1

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2014

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…A Phase II study of SBRT for the treatment of inoperable primary or locally recurrent endometrial and cervical cancers was discussed [9]. Patients with contraindications to surgery or brachytherapy were treated with either SBRT alone (40 Gy in five fractions) or 45 Gy IMRT plus SBRT (40 Gy in five fractions).…”

Section: Gynecologicalmentioning

confidence: 99%

Best of the Radiosurgery Society ^® Scientific Meeting 2014: stereotactic Radiosurgery/Stereotactic Body Radiotherapy Treatment of Extracranial and Intracranial Lesions

Mahadevan¹,

Bucholz²,

Gaya³

et al. 2014

Future Oncol.

View full text Add to dashboard Cite

The SRS/SBRT Scientific Meeting 2014, Minneapolis, MN, USA, 7–10 May 2014 The Radiosurgery Society®, a professional medical society dedicated to advancing the field of stereotactic radiosurgery (SRS) and stereotactic body radiotherapy (SBRT), held the international Radiosurgery Society Scientific Meeting, from 7–10 May 2014 in Minneapolis (MN, USA). This year's conference attracted over 400 attendants from around the world and featured over 100 presentations (46 oral) describing the role of SRS/SBRT for the treatment of intracranial and extracranial malignant and nonmalignant lesions. This article summarizes the meeting highlights for SRS/SBRT treatments, both intracranial and extracranial, in a concise review.

show abstract

Section: Gynecologicalmentioning

confidence: 99%

Best of the Radiosurgery Society ^® Scientific Meeting 2014: stereotactic Radiosurgery/Stereotactic Body Radiotherapy Treatment of Extracranial and Intracranial Lesions

Mahadevan¹,

Bucholz²,

Gaya³

et al. 2014

Future Oncol.

View full text Add to dashboard Cite

show abstract

Stereotactic body radiation therapy as an emerging ablative therapy for recurrent gynecologic cancer: Early disease and quality of life outcomes from a phase II trial

Cited by 1 publication

References 0 publications

Best of the Radiosurgery Society ^® Scientific Meeting 2014: stereotactic Radiosurgery/Stereotactic Body Radiotherapy Treatment of Extracranial and Intracranial Lesions

Best of the Radiosurgery Society ^® Scientific Meeting 2014: stereotactic Radiosurgery/Stereotactic Body Radiotherapy Treatment of Extracranial and Intracranial Lesions

Contact Info

Product

Resources

About

Stereotactic body radiation therapy as an emerging ablative therapy for recurrent gynecologic cancer: Early disease and quality of life outcomes from a phase II trial

Cited by 1 publication

References 0 publications

Best of the Radiosurgery Society ® Scientific Meeting 2014: stereotactic Radiosurgery/Stereotactic Body Radiotherapy Treatment of Extracranial and Intracranial Lesions

Best of the Radiosurgery Society ® Scientific Meeting 2014: stereotactic Radiosurgery/Stereotactic Body Radiotherapy Treatment of Extracranial and Intracranial Lesions

Contact Info

Product

Resources

About

Best of the Radiosurgery Society ^® Scientific Meeting 2014: stereotactic Radiosurgery/Stereotactic Body Radiotherapy Treatment of Extracranial and Intracranial Lesions

Best of the Radiosurgery Society ^® Scientific Meeting 2014: stereotactic Radiosurgery/Stereotactic Body Radiotherapy Treatment of Extracranial and Intracranial Lesions